Towa Pharmaceutical Co., Ltd. (TWAPF) reported a profit for full year that Dropped, from last year
The company's bottom line totaled JPY5.250 billion, or JPY106.66 per share. This compares with JPY18.986 billion, or JPY385.71 per share, last year.
The company's revenue for the period rose 5.4% to JPY273.710 billion from JPY259.594 billion last year.
Towa Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: JPY5.250 Bln. vs. JPY18.986 Bln. last year.-EPS: JPY106.66 vs. JPY385.71 last year.-Revenue: JPY273.710 Bln vs. JPY259.594 Bln last year.
-Guidance:Full year EPS guidance: JPY 436.75Full year revenue guidance: JPY 304.000 B
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.